Cama Elena, Brener Loren, Slavin Sean, de Wit John
a Centre for Social Research in Health , University of New South Wales , Sydney , NSW , Australia.
AIDS Care. 2015;27(6):739-42. doi: 10.1080/09540121.2014.998614. Epub 2015 Jan 7.
HIV-related stigma has been linked to avoidance of health care services and suboptimal adherence to antiretroviral therapy (ART). However, less is known about concerns of stigma related specifically to the taking of ART in uptake of treatment. This study examines experiences of HIV treatment-related stigma and assesses if these experiences are associated with ART uptake, independent of general HIV-related stigma. People living with HIV (PLHIV; n = 697) were targeted to complete an online questionnaire measuring perceived HIV- and treatment-related stigma, social support, self-esteem, resilience, psychological distress, health satisfaction and quality of life. Findings suggest that experiences of general and treatment-related stigma were common, and that participants appear to experience greater stigma related to taking HIV treatment than general stigma associated with HIV. Neither general nor treatment-related stigma uniquely impacted HIV treatment uptake. Instead, treatment uptake was associated with being older (adjusted OR 1.05; 95% CIs: 1.03, 1.08), greater duration of HIV infection (adjusted OR 1.07; 95% CIs: 1.03-1.11) and having greater health satisfaction (adjusted OR 1.28; 95% CIs: 1.03, 1.59). Findings highlight that concerns around taking HIV treatment can be an added source of stigma for PLHIV, however other factors may be greater contributors to the likelihood of taking HIV treatment.
与艾滋病病毒相关的污名化与避免医疗服务以及对抗逆转录病毒疗法(ART)的依从性欠佳有关。然而,对于在接受治疗过程中与服用抗逆转录病毒疗法药物具体相关的污名化问题,我们了解得较少。本研究调查了与艾滋病病毒治疗相关的污名化经历,并评估这些经历是否与接受抗逆转录病毒疗法有关,且独立于一般的与艾滋病病毒相关的污名化。针对697名艾滋病病毒感染者(PLHIV)完成了一份在线问卷,该问卷测量了感知到的与艾滋病病毒及治疗相关的污名化、社会支持、自尊、恢复力、心理困扰、健康满意度和生活质量。研究结果表明,一般污名化和与治疗相关的污名化经历很常见,而且参与者似乎在服用艾滋病病毒治疗药物方面比与艾滋病病毒相关的一般污名化经历了更大的污名化。一般污名化和与治疗相关的污名化都没有对艾滋病病毒治疗的接受情况产生独特影响。相反,接受治疗与年龄较大(调整后的比值比为1.05;95%置信区间:1.03,1.08)、艾滋病病毒感染持续时间较长(调整后的比值比为1.07;95%置信区间:1.03 - 1.11)以及健康满意度较高(调整后的比值比为1.28;95%置信区间:1.03,1.59)有关。研究结果突出表明,对于艾滋病病毒感染者而言,围绕服用艾滋病病毒治疗药物的担忧可能是污名化的一个额外来源,然而其他因素可能是接受艾滋病病毒治疗可能性的更大促成因素。